Evidence map›Paper›PMID 38123783›Full record

ArticleObesity surgery2024

Endoscopic Revisional Gastroplasty After Bariatric Surgery with a Single-Channel Endoscope.

Thierry Manos, Anamaria Nedelcu, Patrick Noel, Christophe Bastid, Christophe Cazeres, Sergio Carandina, Marius Nedelcu

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Thierry ManosELSAN, Clinique Bouchard, Marseille, France.
Anamaria NedelcuCentre Chirurgical de L'Obésité, ELSAN, Clinique Saint Michel, Place du 4 Septembre, 83100, Toulon, France.
Patrick NoelELSAN, Clinique Bouchard, Marseille, France.
Christophe BastidELSAN, Clinique Bouchard, Marseille, France.
Christophe CazeresClinique Les Orchidées, Réunion, France.
Sergio CarandinaCentre Chirurgical de L'Obésité, ELSAN, Clinique Saint Michel, Place du 4 Septembre, 83100, Toulon, France.
Marius NedelcuELSAN, Clinique Bouchard, Marseille, France. nedelcu.marius@gmail.com.ORCID 0000-0002-2414-3511
Hôpital Saint-Michel · FRClinique Claude-Bernard · FRDubai Health Authority · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLess invasive endoscopic bariatric procedures are under development for the management of recurrence of obesity. The purpose of the current manuscript was to evaluate the safety of the endoscopic revisional gastroplasty (ERG) for patients with recurrence of weight gain following different bariatric procedures. MATERIALS AND

methodsThis is a retrospective single-center study over 22 patients using the ERG between January 2020 to July 2022 at Bouchard Private Hospital (Marseille, France). The demographic data, past surgical history, obesity complications, time interval between the surgical and endoscopic procedures, and intra and postoperative parameters and outcomes were analyzed.

resultsA total of 22 patients underwent ERG: 19 female (86.4%) with a mean age of 34.2 years and a mean BMI of 32.9 kg/m

conclusionEndoscopic revisional gastroplasty represents a safe minimal invasive approach that can be considered an effective and well-tolerated procedure for patients with previous bariatric surgery.

Indexed as

Bariatric SurgeryGastric BypassGastroplastyLaparoscopyObesity, MorbidAdultEndoscopesFemaleHumansObesityReoperationRetrospective StudiesTreatment OutcomeBariatric surgeryEndoscopic gastroplastyEndoscopic plicationObesity

Identifiers

PMID38123783
OpenAlexW4390053704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.